Early detection doesn't prevent Type 1 diabetes. It prevents the emergency room.

When red blood cells rupture during sample collection or transport, they release hemoglobin into the serum. This hemoglobin absorbs light at the same wavelengths used in ELISA optical detection, creating false-low or unreliable absorbance readings. In pediatric collections — where small veins increase the likelihood of hemolyzed samples — this is a frequent cause of repeat draws. ADAP's PCR-based amplification and digital detection is completely immune to optical interference from hemolysis, meaning even imperfect samples produce reliable results.

Biotin (vitamin B7) is a widely used supplement found in prenatal vitamins, hair-growth formulas, and multivitamins. At high doses, biotin directly competes with the biotin-streptavidin bridge that forms the core detection mechanism in most ELISA and immunoassay platforms. This competition can produce false-negative results, giving families a dangerous false sense of security. An estimated 15% of patients taking supplements are at risk. ADAP does not rely on biotin-streptavidin binding at any step, so supplement use has zero impact on test accuracy.

Human anti-animal antibodies (HAMAs) and rheumatoid factor can non-specifically bind to the capture and detection antibodies used in sandwich ELISA assays, creating bridging signals that mimic true positives. These false-positive results can lead to unnecessary anxiety, further invasive testing, and misallocation of clinical resources. Heterophilic antibody interference affects an estimated 3–5% of serum samples. ADAP's unique agglutination-PCR mechanism uses DNA-tagged antibody detection that is structurally incompatible with heterophilic bridging, eliminating this entire class of false positives.

Elevated lipid levels (lipemia) cause sample turbidity that scatters light, while elevated bilirubin (icterus) absorbs light at overlapping wavelengths with assay chromogens. Both conditions corrupt the absorbance readings that ELISA depends on for quantification. Post-meal blood draws, neonatal jaundice, and liver conditions all increase the prevalence of these interferents. ADAP converts antibody binding into a digital PCR signal — a fundamentally different readout that is unaffected by sample opacity, color, or turbidity.